Tokyo-Eki Center-building Clinic | Tokyo, Japan

Research site
3-3-11 Nihonbashi, Chuo-ku, Tokyo, Japan
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


5 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

The main purpose of this study is to determine the efficacy and safety of LY3819469 in adults with elevated lipoprotein(a). The study will lasts abou...

Active, not recruiting
Lipoprotein Disorder
Drug: LY3819469
Drug: Placebo

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The primary...

Familial Hypercholesterolemia
Drug: MK-0616
Drug: Placebo

This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-rela...

Active, not recruiting
Overweight or Obesity
Drug: Placebo
Drug: Orforglipron

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Olpasiran

Trial conditions

Atherosclerosis (2 trials)
Cardiovascular Diseases (2 trials)
Hypercholesterolemia (1 trial)
Hyperlipoproteinemia Typ... (1 trial)
Obesity (1 trial)
Overweight (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems